Latest News about JNJ
Recent news which mentions JNJ
From InvestorPlace
 From InvestorPlace
 
   Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
   
  
  
  July 24, 2024
  From Benzinga
 
   Pharma Giant Johnson & Johnson Asks FDA To Approve Esketamine Nasal Spray For Treatment-Resistant Depression
   
  
  
  July 23, 2024
  From Benzinga
 
   Biden's Exit From Presidential Race 'Yet Another Curveball For Equity Investors': Analysts
   
  
  
  July 22, 2024
  From Benzinga
 From Benzinga
 From Benzinga
 
   This Hidden Gem Vanguard ETF Is Chock-Full of Magnificent Stocks. Here's Why It's a Buy Now.
   
  
  
  July 21, 2024
  From Motley Fool
 
   3 Blue-Chip Stocks to Buy for Christmas in July
   
  
  
  July 19, 2024
  From InvestorPlace
 From InvestorPlace
 
   Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst
   
  
  
  July 18, 2024
  From Benzinga
 
   3 Dividend Stocks That Demand Investor Attention
   
  
  
  July 18, 2024
  From InvestorPlace
 From Benzinga
 
   Comparative Study: Johnson & Johnson And Industry Competitors In Pharmaceuticals Industry
   
  
  
  July 18, 2024
  From Benzinga
 
   3 Blue-Chip Stocks to Buy If the Dow Crashes
   
  
  
  July 18, 2024
  From InvestorPlace
 From Benzinga
 From Motley Fool
 From Benzinga
 From Motley Fool
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.